日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

2025年泌尿系统晚期肿瘤共识会议(AUC3):肾细胞癌和泌尿系统肿瘤治疗的专家共识

McKay, Rana R; Pal, Sumanta; Xie, Wanling; Aggen, David; Albiges, Laurence; Apolo, Andrea; Atkins, Michael B; Bangs, Rick; Beckermann, Kathryn E; Bellmunt, Joaquim; Berg, Stephanie A; Bilen, Mehmet A; Braun, David; Carlo, Maria I; Efstathiou, Jason; Galsky, Matthew; Grivas, Petros; Gupta, Shilpa; Haas, Naomi; Hakimi, A Ari; Hammers, Hans; Heng, Daniel Y C; Hirsch, Michelle; Iyer, Gopakumar; Jonasch, Eric; Koshkin, Vadim S; Kryvenko, Oleksandr; Lewis, Bryan; Li, Roger; Matin, Surena; Maughan, Benjamin; McDermott, David F; McGregor, Bradley; Meeks, Joshua; Milowsky, Matthew; Motzer, Robert; Necchi, Andrea; Petrylak, Dan; Porten, Sima; Powles, Thomas; Rini, Brian; Shuch, Brian; Siefker-Radtke, Arlene; Sonpavde, Guru; Sridhar, S Srikala; Suarez, Cristina; Tang, Chad; Tripathi, Abhishek; Van Der Heijden, Michiel S; Voss, Martin; Xu, Wenxin; Zhang, Tian; Rosenberg, Jonathan; Choueiri, Toni K

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA Targeted Tubulysin Conjugate EC1169

在PSMA靶向Tubulysin缀合物EC1169的I期研究中,对CTC上PSMA表达进行相关性生物标志物分析和PSMA成像

Zaidi, Samir; Kuo, Phillip H; Paiva Prudente, Tiago; Lacuna, Kristine P; Babiker, Hani M; Aparicio, Renan; Schonhoft, Joseph D; Fernandez, Luisa; Messmann, Richard; Groaning, Michael; Tolcher, Anthony W; Gordon, Michael S; Yoo, Don C; Vaishampayan, Ulka; Picus, Joel; Petrylak, Daniel P; Sartor, Oliver; Morris, Michael J

How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study

与铂类化疗相比,恩福妥单抗联合帕博利珠单抗治疗对晚期尿路上皮癌患者生活质量的影响:EV-302 研究患者报告结局的简明语言总结

Gupta, Shilpa; Loriot, Yohann; Van der Heijden, Michiel S; Bedke, Jens; Valderrama, Begoña P; Kikuchi, Eiji; Fléchon, Aude; Petrylak, Daniel; De Santis, Maria; Galsky, Matthew D; Lee, Jae Lyun; Swami, Umang; Sridhar, Srikala S; De Giorgi, Ugo; Wright, Phoebe; Shih, Vanessa; Lu, Yi-Tsung; Guan, Xuesong; Dillon, Ryan; Shetty, Aditya; Homet Moreno, Blanca; Beaumont, Jennifer L; Purnajo, Intan; McManus, Shauna; Powles, Thomas

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial

帕博利珠单抗联合多西他赛对比单药多西他赛治疗既往接受过治疗的转移性去势抵抗性前列腺癌:随机、双盲、III期KEYNOTE-921试验

Petrylak, Daniel P; Ratta, Raffaele; Matsubara, Nobuaki; Korbenfeld, Ernesto; Gafanov, Rustem; Mourey, Loic; Todenhöfer, Tilman; Gurney, Howard; Kramer, Gero; Bergman, Andries M; Zalewski, Pawel; De Santis, Maria; Armstrong, Andrew J; Gerritsen, Winald; Pachynski, Russell; Byun, Seok Soo; Retz, Margitta; Levesque, Eric; McDermott, Ray; Bracarda, Sergio; Manneh, Ray; Levartovsky, Meital; Li, Xin Tong; Schloss, Charles; Poehlein, Christian H; Fizazi, Karim

Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer

非孔道核孔蛋白sPOM121转录促进前列腺癌中β-catenin驱动的肿瘤进展和免疫逃逸

Perumalraja Kirthika #,Vijayakumar Jawalagatti #,Peiyao Li #,Michael Xu,Marc Carceles-Cordon,Adam Ertel,S Aidan Quinn,Daniel P Petrylak,Jacob J Orme,Scott M Dehm,Emmanuel S Antonarakis,Elisabeth I Heath,Mukesh K Pandey,Carlos Cordon-Cardo,Haojie Huang,Haidong Dong,Shijia Zhu,Josep Domingo-Domenech,Veronica Rodriguez-Bravo

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial

恩扎卢胺和前列腺特异性抗原水平在转移性前列腺癌中的作用:ARCHES随机临床试验的二次分析

Azad, Arun A; Petrylak, Daniel P; Iguchi, Taro; Shore, Neal D; Villers, Arnauld; Gomez-Veiga, Francisco; Alcaraz, Antonio; Alekseev, Boris; Szmulewitz, Russell Z; Holzbeierlein, Jeffrey; Rosbrook, Brad; Ma, Jie; Zohren, Fabian; El-Chaar, Nader N; Haas, Gabriel P; Stenzl, Arnulf; Armstrong, Andrew J

Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients

Avelumab一线维持治疗晚期尿路上皮癌:JAVELIN Bladder 100试验中老年患者的长期疗效

Gupta, S; Climent Duran, M A; Sridhar, S S; Powles, T; Bellmunt, J; Park, S H; Gurney, H; Tsuchiya, N; Petrylak, D P; Tomita, Y; di Pietro, A; Manitz, J; Tyroller, K; Hoffman, J; Jacob, N; Grivas, P

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024

针对生化复发和晚期前列腺癌患者实施循证策略:2024 年美国前列腺癌大会共识建议

Bryce, Alan H; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S; Armstrong, Andrew J; Calais, Jeremie; Carducci, Michael A; Dorff, Tanya Barauskas; Efstathiou, Jason A; Gleave, Martin; Gomella, Leonard G; Higano, Celestia; Hope, Thomas A; Iagaru, Andrei; Morgans, Alicia K; Morris, David S; Morris, Michael J; Petrylak, Daniel P; Reiter, Robert E; Rettig, Matthew B; Ryan, Charles J; Sellinger, Scott B; Spratt, Daniel E; Srinivas, Sandy; Tagawa, Scott T; Taplin, Mary-Ellen; Yu, Evan Y; Zhang, Tian; McKay, Rana R; Koo, Phillip J; Crawford, E David

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab

晚期尿路上皮癌患者(不适合接受顺铂治疗)接受一线恩福妥单抗单药治疗或联合帕博利珠单抗治疗的患者报告结局

Milowsky, Matthew I; O'Donnell, Peter H; Hoimes, Christopher J; Petrylak, Daniel P; Flaig, Thomas W; Moon, Helen H; Friedlander, Terence W; Mar, Nataliya; McKay, Rana R; Srinivas, Sandy; Gravis, Gwenaelle; Ramamurthy, Chethan; Bupathi, Manojkumar; Bracarda, Sergio; Wright, Phoebe; Hepp, Zsolt; Carret, Anne-Sophie; Yu, Yao; Dillon, Ryan; Kataria, Ritesh; Beaumont, Jennifer L; Purnajo, Intan; Rosenberg, Jonathan E

TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy

TROPHY-U-01 队列 2:一项针对既往接受过免疫检查点抑制剂治疗后进展且不适合顺铂治疗的转移性尿路上皮癌患者的 Sacituzumab Govitecan II 期研究

Petrylak, Daniel P; Tagawa, Scott T; Jain, Rohit K; Bupathi, Manojkumar; Balar, Arjun; Kalebasty, Arash Rezazadeh; George, Saby; Palmbos, Phillip; Nordquist, Luke; Davis, Nancy; Ramamurthy, Chethan; Sternberg, Cora N; Loriot, Yohann; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Vance, Morganna; Zhou, Huafeng; Grivas, Petros